DEA disagrees with firm's meth-resistant claims

by Jim Salter

The Drug Enforcement Administration says a suburban St. Louis pharmaceutical company is wrong for marketing its pseudoephedrine product to imply methamphetamine cannot be made with it.

But Westport Pharmaceuticals insists its Zephrex-D is impractical as an ingredient for meth, even if small amounts of the drug can be extracted from it. The Maryland Heights, Mo., company began selling the cold and allergy medication last year.

The DEA's acting special agent in charge of the St. Louis office, James Shroba, sent Westport a letter dated May 6 and called the company out on its marketing of Zephrex-D as meth-resistant.

Westport spokeswoman Emilie Dolan said Tuesday that only small amounts of meth can be extracted. She says it would cost meth-makers $250 to $500 to make a single dose using Zephrex-D.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

DEA demonstrates how to make meth

May 29, 2007

The Drug Enforcement Administration a held methamphetamine making seminar in Denver to demonstrate what its agents keep off the streets.

Toward a vaccine for methamphetamine abuse

May 11, 2011

Scientists are reporting development of three promising formulations that could be used in a vaccine to treat methamphetamine addiction — one of the most serious drug abuse problems in the U.S. The report ...

Meds can help recovering meth addicts stay sober

Jun 14, 2012

(Medical Xpress) -- A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments